Back to search results

MAYA Mobile App for Anxiety and Depression in Middle-Aged and Older Adults

This study is testing a mobile app called MAYA, which teaches coping skills based on cognitive behavioral therapy (CBT) for anxiety and depression. It's designed for adults aged 40 and older who have been diagnosed with an anxiety or depressive disorder. The main goal is to see how acceptable and easy to use the MAYA app is for participants. You would use the app for at least 20 minutes, two days a week, for six weeks. There will be weekly check-ins and assessments at the beginning, middle, and end of the treatment, plus a follow-up. This study is currently recruiting about 60 participants.

Study design
This is an interventional study with a planned enrollment of 60 participants. All participants will use the MAYA app, and there is no control group.
What's involved
You would use the MAYA app for at least 20 minutes, two days a week, for six weeks. There will be weekly check-ins and longer assessments at the beginning, week 3, week 6, and week 12.
Compensation
Not stated in the trial record.
Follow-up
Participants will have a follow-up assessment at week 12, which is six weeks after the end of treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05754151

Mobile CBT for Middle Aged and Older Adults

Recruiting
NAAges 40+InterventionalSupportive care
Weill Medical College of Cornell University
~60 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:MAYA Mobile Application

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of the MAYA application as measured by mean uMARS scores at Baseline
Measured over Week 1 (Baseline)
+4 more outcomes measured

Conditions

Anxiety Disorders and Symptoms
Depressive Symptoms
Depression

Explore related trials

Anxiety DisorderDepressive disorder

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Jennifer Bress, Ph.D. · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University

Who to contact

Maddy Schier
[email protected]
(646) 289-5271 · ext. 720
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 40 or older
Primary diagnosis of an anxiety or depressive disorder as determined by a clinical severity rating score of 4 or greater on the Anxiety Disorders Interview Schedule (ADIS).
Mini Mental Status Exam (MMSE) no more than 1 SD below the mean score for patient's age and education. If the remote version of the MMSE is used (e.g. during an evaluation on Zoom), the remote MMSE score will be converted to a standard MMSE score.
Access to an Apple iPhone, iPad, or Android device.

Exclusion

Lifetime diagnosis of a bipolar or psychotic disorder.
Currently in cognitive behavior therapy.
Change in dose of a psychiatric medication in the past 12 weeks.
Initiation of psychotherapy in the past 12 weeks.
Intent or plan to attempt suicide.

What this trial measures

  • Acceptability of the MAYA application as measured by mean uMARS scores at BaselineWeek 1 (Baseline)

    The primary measure to assess accessibility of the MAYA app will be the User Version of the Mobile Application Rating Scale (uMARS). The uMARS is a 26-item questionnaire that evaluates the quality of the mobile health applications with six subscales: engagement, functionality, aesthetics, information, app subjective quality, perceived impact. Scores on the scale can range from 21 to 130, where higher scores represent higher quality of mobile health applications by end-users.

  • Acceptability of the MAYA application as measured by mean uMARS scores at MidpointWeek 3 (Midpoint)

    The primary measure to assess accessibility of the MAYA app will be the User Version of the Mobile Application Rating Scale (uMARS). The uMARS is a 26-item questionnaire that evaluates the quality of the mobile health applications with six subscales: engagement, functionality, aesthetics, information, app subjective quality, perceived impact. Scores on the scale can range from 21 to 130, where higher scores represent higher quality of mobile health applications by end-users.

  • Acceptability of the MAYA application as measured by mean uMARS scores at EndpointWeek 6 (Endpoint)

    The primary measure to assess accessibility of the MAYA app will be the User Version of the Mobile Application Rating Scale (uMARS). The uMARS is a 26-item questionnaire that evaluates the quality of the mobile health applications with six subscales: engagement, functionality, aesthetics, information, app subjective quality, perceived impact. Scores on the scale can range from 21 to 130, where higher scores represent higher quality of mobile health applications by end-users.

  • Feasibility of the MAYA application as measured by total number of sessions completed in the MAYA application at EndpointWeek 6 (Endpoint)

    Total number of sessions completed by the end of the administered intervention

  • Feasibility of the MAYA application as measured by total number of sessions completed in the MAYA application at Follow UpWeek 12 (Follow Up)

    Total number of sessions completed by the end of the administered intervention